Supplier News Breaks Archives
J&J appoints vice chairmen in executive moves
December 15th, 2010
NEW BRUNSWICK, N.J. – Johnson & Johnson has named Alex Gorsky and Sheri McCoy as vice chairmen of its executive committee and said they will join board chairman and chief executive officer William Weldon in an expanded office of the chairman.
The health care giant said Wednesday that the appointments of Gorsky, currently worldwide chairman of medical devices and diagnostics, and McCoy, currently worldwide chairman of pharmaceuticals, are effective Jan. 3.
"Alex and Sheri are proven leaders in driving high performance and developing talent across multiple business segments. These appointments will ensure we are well-positioned for sustainable growth into the future," Weldon said in a statement. "The changes are an appropriate step in furthering our long-term succession plans and assuring talented, experienced leaders at all levels of the organization."
Gorsky, 50, will take on expanded responsibilities that include the Medical Device & Diagnostics (MD&D) Group, Global Supply Chain, Government Affairs & Policy and the Johnson & Johnson Development Corp., according to J&J. Meanwhile, the 52-year-old McCoy will assume added duties that include the Pharmaceuticals Group, Consumer Group, the Corporate Office of Science & Technology and Corporate Affairs.
J&J also announced a series of other leadership changes.
Michael Mahoney, currently company group chairman for DePuy, has been named worldwide chairman of MD&D and will report to Gorsky. Jesse Wu, now company group chairman for the consumer global markets organization, has been appointed worldwide chairman for consumer and will report to McCoy.
Also reporting to McCoy will be Joaquin Duato, formerly Pharmaceuticals Company Group chairman for the Americas, who has been named worldwide chairman for pharmaceuticals with responsibility for commercial businesses and operations, and Paul Stoffels, currently global head of pharmaceuticals research and development, who has been appointed worldwide chairman Pharmaceuticals with responsibility for research and development, business development and strategic development.
In addition, J&J said that Peter Fasolo, worldwide vice president of human resources, will join the executive committee and continue to focus on talent development and succession planning at all levels of the company.
"These leadership changes are designed to ensure that our company remains well-positioned and appropriately structured for sustainable, long-term growth in the health care industry," Weldon stated.